The 5% profits over costs is promising, even if it leaves some wiggle room.
(No, I'm not a nutcase, but, yes, this really is Vaccine Damage Awareness Month. 'Tis the season to kill people by demonizing an extremely safe form of preventative treatment by spreading baseless rumors to sow irrational fear.)
GSK has a mixed history when it comes to stuff like this, let's hope they do the right thing here. I note they didn't say the doses will cost at most 'x' (which they should have a pretty good idea of by now).
if GSK didn't pay for those, the malaria vaccine wouldn't exist; those are real costs that GSK paid. if they were always compensated on certain drugs only based on cost of manufacturing, they would simply never research those drugs.